Literature DB >> 8763889

Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content.

M W Dewhirst1, E T Ong, G L Rosner, S W Rehmus, S Shan, R D Braun, D M Brizel, T W Secomb.   

Abstract

Carbogen is thought to be more effective than normobaric oxygen in reducing tumour hypoxia because it may reduce hyperoxic vasoconstriction. In this study, tumour and normal arteriolar diameters were measured simultaneously with perivascular pO2 during air breathing followed by either carbogen or 100% oxygen to determine whether the action of carbogen is the result of alterations in feeding vessel diameter. Fischer-344 rats bearing dorsal flap window chambers, with or without implanted R3230AC tumours, were the experimental subjects. Arteriolar diameters were measured using optical techniques and perivascular pO2 was measured using recessed-tip electrodes (3-6 microns tip diameter). Baseline arteriolar pO2 averaged 30-50% of blood gas pO2 (mean = 97 mmHg). Both hyperoxic gases increased blood gas pO2 by 4-to 5-fold, but relative improvements in arteriolar pO2 were < or = 2.5 for all arterioles studied. This means that these normobaric high O2 gases are not very efficient in increasing O2 delivery to tumours. In addition, improvements in tumour arteriolar pO2 were transient for both hyperoxic gases. Oxygen and carbogen caused no change and mild vasodilatory responses in tumour arterioles, respectively. Normal arterioles on the other hand, tended toward vasoconstriction by carbogen breathing. Peri-arteriolar pO2 in tumours increased within the first 5 min of breathing either hyperoxic gas, followed by a decline back toward values seen with air-breathing. These results suggest that temporal changes in tumour oxygenation after exposure to carbogen or O2 may not be due to changes in perfusion. Other factors, such as changes in O2 consumption rate may be involved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763889      PMCID: PMC2149985     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  26 in total

1.  ARCON: accelerated radiotherapy with carbogen and nicotinamide.

Authors:  A Rojas
Journal:  BJR Suppl       Date:  1992

2.  Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow.

Authors:  B R Duling; R M Berne
Journal:  Circ Res       Date:  1970-11       Impact factor: 17.367

3.  A transparent access chamber for the rat dorsal skin fold.

Authors:  H D Papenfuss; J F Gross; M Intaglietta; F A Treese
Journal:  Microvasc Res       Date:  1979-11       Impact factor: 3.514

4.  The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma.

Authors:  D W Siemann; R P Hill; R S Bush
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

5.  Long-term micro- and macrocirculatory measurements in conscious rats.

Authors:  T L Smith; S W Osborne; P M Hutchins
Journal:  Microvasc Res       Date:  1985-05       Impact factor: 3.514

6.  Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor.

Authors:  S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-01       Impact factor: 7.038

Review 7.  A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.

Authors:  E Kjellen; M C Joiner; J M Collier; H Johns; A Rojas
Journal:  Radiother Oncol       Date:  1991-10       Impact factor: 6.280

8.  The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.

Authors:  D M Brizel; S Lin; J L Johnson; J Brooks; M W Dewhirst; C A Piantadosi
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

9.  The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography.

Authors:  S J Falk; R Ward; N M Bleehen
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

10.  The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment.

Authors:  B D Kavanagh; B E Coffey; D Needham; R M Hochmuth; M W Dewhirst
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more
  12 in total

1.  Regulation of proliferation-survival decisions during tumor cell hypoxia.

Authors:  C Schmaltz; P H Hardenbergh; A Wells; D E Fisher
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

2.  Implanted cell-dense prevascularized tissues develop functional vasculature that supports reoxygenation after thrombosis.

Authors:  Sean M White; Chelsea R Pittman; Ryan Hingorani; Rajan Arora; Tatiana V Esipova; Sergei A Vinogradov; Christopher C W Hughes; Bernard Choi; Steven C George
Journal:  Tissue Eng Part A       Date:  2014-06-30       Impact factor: 3.845

3.  Pd-porphyrin-cross-linked implantable hydrogels with oxygen-responsive phosphorescence.

Authors:  Haoyuan Huang; Wentao Song; Guanying Chen; Justin M Reynard; Tymish Y Ohulchanskyy; Paras N Prasad; Frank V Bright; Jonathan F Lovell
Journal:  Adv Healthc Mater       Date:  2013-11-20       Impact factor: 9.933

4.  Measuring tumor cycling hypoxia and angiogenesis using a side-firing fiber optic probe.

Authors:  Bing Yu; Amy Shah; Bingqing Wang; Narasimhan Rajaram; Quanli Wang; Nirmala Ramanujam; Gregory M Palmer; Mark W Dewhirst
Journal:  J Biophotonics       Date:  2012-12-14       Impact factor: 3.207

5.  Combined hyperspectral and spectral domain optical coherence tomography microscope for noninvasive hemodynamic imaging.

Authors:  Melissa C Skala; Andrew Fontanella; Hansford Hendargo; Mark W Dewhirst; Joseph A Izatt
Journal:  Opt Lett       Date:  2009-02-01       Impact factor: 3.776

6.  The effects of hyperoxic and hypercarbic gases on tumour blood flow.

Authors:  T J Dunn; R D Braun; W E Rhemus; G L Rosner; T W Secomb; G M Tozer; D J Chaplin; M W Dewhirst
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.

Authors:  S R Khandelwal; B D Kavanagh; P S Lin; Q T Truong; J Lu; D J Abraham; R K Schmidt-Ullrich
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

8.  Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging.

Authors:  Amy F Martinez; Samuel S McCachren; Marianne Lee; Helen A Murphy; Caigang Zhu; Brian T Crouch; Hannah L Martin; Alaattin Erkanli; Narasimhan Rajaram; Kathleen A Ashcraft; Andrew N Fontanella; Mark W Dewhirst; Nirmala Ramanujam
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

9.  The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a.

Authors:  M Stubbs; S P Robinson; L M Rodrigues; C S Parkins; D R Collingridge; J R Griffiths
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

10.  Effects of hyperoxia on vascular tone in animal models: systematic review and meta-analysis.

Authors:  Bob Smit; Yvo M Smulders; Etto C Eringa; Heleen M Oudemans-van Straaten; Armand R J Girbes; Kimberley E Wever; Carlijn R Hooijmans; Angelique M E Spoelstra-de Man
Journal:  Crit Care       Date:  2018-08-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.